Dossiers d'AMM à étudier par le Comité Technique des Spécialités Pharmaceutiques du 17/07/2019.
Pour ce comité technique, l’ordre de passage des dossiers sera comme suit .
Spécialités Pharmaceutiques importées :
* Produits déjà évalués lors des derniers Comités Techniques
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE courrier |
1 | PRAXBIND | IDARUCIZUMAB | 2,5G/50ML | SOL INJ PERFUSION | B/2FL/50ML | BOEHRINGER INGELHEIM | V | N | 15/03/2019 |
2 | PROLUTEX | PROGESTERONE | 25MG | SOL INJ | B/7FL | IBSA Institut Biochimique SA | N | 27/03/2019 | |
3 | ATACAND | Candesertan Cilexetil | 4mg | CP | B/30 | ASTRA ZENECA | E | V | 22/04/2019 |
4 | ATACAND | Candesertan Cilexetil | 8mg | CP | B/30 | ASTRA ZENECA | E | V | 22/04/2019 |
5 | ATACAND | Candesertan Cilexetil | 16mg | CP | B/30 | ASTRA ZENECA | E | V | 22/04/2019 |
6 | MIRVASO | BRIMONIDINE TARTRATE | 3mg/gr | Gel dermique | T / 30gr | GALDERMA INTERNATIONAL | C | N | 22/05/2019 |
7 | XARELTO | RIVAROXABAN | 15mg | Cp | B42 | BAYER | E | N | 29/05/2019 |
8 | XARELTO | RIVAROXABAN | 15mg | Cp | B28 | BAYER | E | N | 29/05/2019 |
9 | XARELTO | RIVAROXABAN | 20mg | Cp | B28 | BAYER | E | N | 29/05/2019 |
10 | LUCENTIS | RANIBIZUMAB | 10MG/ML | SOL INJ | B/1FL | NOVARTIS | E | V | 27/06/2019 |
11 | DuoPlavin | CLOPIDOGREL+ ACIDE ACETYLSALICYLIQUE | 75mg/100mg | cp pelliculé | b/28 | SANOFI AVENTIS | E | N | 12/07/2019 |
12 | BETMIGA | MIRABEGRON | 50MG | COMP LIB PRO | B/30 | ASTRELLAS | E | N | 16/07/2019 |
* Produits à évaluer pour la première fois au Comité Technique (AO)
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de demande | DATE courrier |
1 | OXALIPLATINE KABI | OXALIPLATINE | 5MG/ML | SOL INJ PERFUSION | B/1FL/20ML | FRESINIUS KABI | V | N | TRANSFERT 12/07/2019 |
2 | OXALIPLATINE KABI | OXALIPLATINE | 5MG/ML | SOL INJ PERFUSION | B/1FL/10ML | FRESINIUS KABI | V | N | TRANSFERT 12/07/2019 |
3 | CAPECITABINE MYLAN | CAPECITABINE | 500MG | COMP PELL | B/120 | MYLAN | V | N | 15/07/2019 |
* Produits à évaluer pour la première fois au Comité Technique
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | TITULAIRE | VEIC | Type de la demande | DATE RE |
1 | AKYNZEO | NETUPITANT+PALONOSETRON | 300MG/0,5MG | GELULE | B/1 | HELSEIN BIREX | N | 27/02/2019 | |
2 | SUXAMETHONIUM CHLORID VUAB | SUXAMETHONIUM CHLORURE | 100MG | PDRE PREP INJ | B/1FL | VUAB PHARMA A/S | V | N | 27/02/2019 |
3 | VIEKIRAX | OMBITASVIR+PARITAPREVIR+RITONAVIR | 12,5/75/50MG | COMP PELLICULE | B/56 | ABBVIE DEUTSCHLAND | E | N | TRANSFERT 22/02/2019 |
4 | EXVIERA | DASABUVIR | 250MG | COMP PELLICULE | B/56 | ABBVIE DEUTSCHLAND | E | N | TRANSFERT 22/02/2019 |
5 | IBRANCE | PALBOCICLIB | 100MG | GELULE | FL/21 | PFIZER INC | V | N | CS 07/03/2019 |
6 | IBRANCE | PALBOCICLIB | 125MG | GELULE | FL/21 | PFIZER INC | V | N | CS 07/03/2019 |
7 | IBRANCE | PALBOCICLIB | 75MG | GELULE | FL/21 | PFIZER INC | V | N | CS 07/03/2019 |
8 | VOTRIENT | PAZOPANIB | 400MG | COMPRIME PELLICULE | FL/30 | NOVARTIS EUROPHARM | V | CS 07/03/2019 | |
9 | VOTRIENT | PAZOPANIB | 200MG | COMPRIME PELLICULE | FL/30 | NOVARTIS EUROPHARM | V | V | CS 07/03/2019 |
10 | ETOPOSIDE MYLAN | ETOPOSIDE | 100MG | SOL INJ | B/10/5ML | MYLAN SAS | V | V | CS 07/03/2019 |
11 | PERJETA | PERTUZUMAB | 420MG | SOL PERF | FL/14ML | ROCHE PHARMA | E | V | CS 07/03/2019 |
12 | DECAPEPTYL LP | TRIPTORELINE | 3MG | PDRE PREP INJ | B/1FL | IPSEN PHARMA | V | V | CS 07/03/2019 |
13 | DECAPEPTYL LP | TRIPTORELINE | 11,25MG | PDRE PREP INJ | B/1FL | IPSEN PHARMA | V | V | CS 07/03/2019 |
14 | LYNPARZA | OLAPARIB | 50MG | GELULE | B/112 | ASTRA ZENECA | V | N | CS 07/03/2019 |
15 | FASLODEX | FLUVESTRANT | 250MG | SOL INJ | B/2/5ML | ASTRA ZENENCA | V | V | CS 07/03/2019 |
16 | LONSURF | TRIFLURIDINE/TIPIRACIL | 15/6,14MG | COMPRIME PELLICULE | B/20 | SERVIER | V | N | CS 07/03/2019 |
17 | LONSURF | TRIFLURIDINE/TIPIRACIL | 20/8,19MG | COMPRIME PELLICULE | B/20 | SERVIER | V | N | CS 07/03/2019 |
18 | ZERBAXA | CEFTOLOZANE+TAZOBACTAM | 1gr/0.5gr | PDRE PERF | B/10FL/20ML | MSD | E | N | 01/04/2019 |
19 | BETAFERON | INTERFERON BETA 1B | 250µg/ML | PDRE PREP INJ | B/15 | BAYER | E | N | TRANSFERT 18/04/2019 |
20 | EYLEA | AFLIBERCEPT | 40 MG/ML | SUSP INH | B/1 | BAYER AG | N | Transfert 25/04/2019 | |
21 | REMIFENTANIL MYLAN | REMIFENTANYL | 5 MG | PDRE PREP INJ | B/10 FL | MYLAN SAS | E | V | CS 03/05/2019 |
22 | REMIFENTANIL MYLAN | REMIFENTANYL | 1 MG | PDRE PREP INJ | B/10 FL | MYLAN SAS | E | V | CS 03/05/2019 |
23 | SPIRIVA RESPIMAT | TIOTROPIUM | 2,5µG/dose | SOIH | B/1UNE CAROUCHE DE 60 DOSES | BOEHRINGER | E | V | CS 03/05/2019 |
24 | NICOPATCH | NICOTINE | 35MG/20 CM | TTS | B/28 | PIERRE FABRE | C | V | CS 03/05/2019 |
25 | NICOPATCH | NICOTINE | 35MG/20 CM | TTS | B/7 | PIERRE FABRE | C | V | CS 03/05/2019 |
26 | NICOPATCH | NICOTINE | 17,5 MG/10 CM | TTS | B/28 | PIERRE FABRE | C | V | CS 03/05/2019 |
27 | NICOPATCH | NICOTINE | 17,5 MG/10 CM | TTS | B/7 | PIERRE FABRE | C | V | CS 03/05/2019 |
28 | NICOPATCH | NICOTINE | 52,5 MG/30 CM | TTS | B/28 | PIERRE FABRE | C | V | CS 03/05/2019 |
29 | NICOPATCH | NICOTINE | 52,5 MG/30 CM | TTS | B/7 | PIERRE FABRE | C | V | CS 03/05/2019 |
30 | NICOPASS | NICOTINE | 2,5 MG | PASTILLES | B/12 | PIERRE FABRE | C | V | CS 03/05/2019 |
31 | NICOPASS | NICOTINE | 2,5 MG | PASTILLES | B/36 | PIERRE FABRE | C | V | CS 03/05/2019 |
32 | NICOPASS | NICOTINE | 2,5 MG | PASTILLES | B/36 | PIERRE FABRE | C | V | CS 03/05/2019 |
33 | NICOPASS | NICOTINE | 2,5 MG | PASTILLES | B/12 | PIERRE FABRE | C | V | CS 03/05/2019 |
34 | NICOPASS | NICOTINE | 1,5 MG | PASTILLES | B/12 | PIERRE FABRE | C | V | CS 03/05/2019 |
35 | NICOPASS | NICOTINE | 1,5 MG | PASTILLES | B/36 | PIERRE FABRE | C | V | CS 03/05/2019 |
36 | TWYNSTA | TELMISARTAN/AMLODIPINE | 80 MG/10 MG | COMPRIME | B/28 | BOEHRINGER | E | V | CS 03/05/2019 |
37 | TWYNSTA | TELMISARTAN/AMLODIPINE | 40 MG/5 MG | COMPRIME | B/28 | BOEHRINGER | E | V | CS 03/05/2019 |
38 | TWYNSTA | TELMISARTAN/AMLODIPINE | 80 MG/5 MG | COMPRIME | B/28 | BOEHRINGER | E | V | CS 03/05/2019 |
39 | TWYNSTA | TELMISARTAN/AMLODIPINE | 40 MG/10 MG | COMPRIME | B/28 | BOEHRINGER | E | V | CS 03/05/2019 |
40 | FRAXIPARINE | NADROPARINE CALCIUM | 5700 UI AXA/0,6ML | SOL INJ | B/2 | ASPEN PHARMA | E | V | CS 03/05/2019 |
41 | FRAXIPARINE | NADROPARINE CALCIUM | 2850 UI Axa | SOL INJ | B/2 | ASPEN PHARMA | E | V | CS 03/05/2019 |
42 | BECLOSPIN | BECLOMETASONE | 800 MG/2ML | SUSP INH | B/20 | CHIESI SAS | E | V | CS 03/05/2019 |
43 | BECLOSPIN | BECLOMETASONE | 400 MG/ML | SUSP INH | B/20 | CHIESI SAS | E | V | CS 03/05/2019 |
44 | LIDOCAINE ADRENALINE | CHLORHYDRATE DE LIDOCAINE /TARTRATE D'ADRENALINE | 20 MG/ML 0,005MG/ML | SOL INJ | B/10 | AGUETTANT France | E | V | CS 03/05/2019 |
45 | LIDOCAINE ADRENALINE | CHLORHYDRATE DE LIDOCAINE /TARTRATE D'ADRENALINE | 10 MG/ML 0,005MG/ML | SOL INJ | B/10 | AGUETTANT France | E | V | CS 03/05/2019 |
46 | XARELTO | RIVAROXABAN | 10 MG | COMPRIME | B/10 | BAYER Allemagne | T/V | CS 03/05/2019 | |
47 | XARELTO | RIVAROXABAN | 10 MG | COMPRIME | B/30 | BAYER Allemagne | T/V | CS 03/05/2019 | |
48 | EZETROL | EZETIMIBE | 10 MG | COMPRIME | B/28 | MSD-SP Ltd | E | V | CS 03/05/2019 |
49 | TAHOR | ATORVASTATINE | 80 MG | COMPRIME | B/30 | PFIZER France | E | V | CS 03/05/2019 |
50 | MENAVEN | HEPARINE SODIQUE | 1000UI/G | GEL DERMIQUE | T/60 GR | MENARINI | C | V | CS 03/05/2019 |
51 | COOLMETEC | OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE | 40 MG/12,5MG | COMPRIME | B/30 | DAIICHI SANKYO | E | V | CS 03/05/2019 |
52 | COOLMETEC | OLMESARTAN MEDOXOMIL/HYDROCHLOROTHIAZIDE | 40 MG/25MG | COMPRIME | B/30 | DAIICHI SANKYO | E | V | CS 03/05/2019 |
53 | LOVENOX | ENOXAPARINE | 8000 UI/0,8 ML | SOL INJ | B/2 | SANOFI AVENTIS | E | V | CS 03/05/2019 |
54 | LOVENOX | ENOXAPARINE | 6000 UI/0,6ML | SOL INJ | B/2 | SANOFI AVENTIS | E | V | CS 03/05/2019 |
55 | LOVENOX | ENOXAPARINE | 4000 UI/0,4ML | SOL INJ | B/2 | SANOFI AVENTIS | E | V | CS 03/05/2019 |
56 | LOVENOX | ENOXAPARINE | 2000 UI/0,2ML | SOL INJ | B/2 | SANOFI AVENTIS | E | V | CS 03/05/2019 |
57 | LOVENOX | ENOXAPARINE | 6000 UI/0,6ML | SOL INJ | B/10 | SANOFI AVENTIS | E | V | CS 03/05/2019 |
58 | LOVENOX | ENOXAPARINE | 4000 UI/0,4ML | SOL INJ | B/6 | SANOFI AVENTIS | E | V | CS 03/05/2019 |
59 | LOVENOX | ENOXAPARINE | 8000 UI/0,8ML | SOL INJ | B/10 | SANOFI AVENTIS | E | V | CS 03/05/2019 |
60 | LOVENOX | ENOXAPARINE | 2000 UI/0,2ML | SOL INJ | B/6 | SANOFI AVENTIS | E | V | CS 03/05/2019 |
61 | INNOHEP | TINZAPARINE SODIQUE | 3500 UI/0,35ML | SOL INJ | B/2 | LEO | E | V | CS 03/05/2019 |
62 | INNOHEP | TINZAPARINE SODIQUE | 14000 UI/0,7ML | SOL INJ | B/2 | LEO | E | V | CS 03/05/2019 |
63 | INNOHEP | TINZAPARINE SODIQUE | 18000 UI/0,9ML | SOL INJ | B/2 | LEO | E | V | CS 03/05/2019 |
64 | INNOHEP | TINZAPARINE SODIQUE | 2500 UI/0,25ML | SOL INJ | B/2 | LEO | E | V | CS 03/05/2019 |
65 | INNOHEP | TINZAPARINE SODIQUE | 10000 UI/0,5ML | SOL INJ | B/2 | LEO | E | V | CS 03/05/2019 |
66 | INNOHEP | TINZAPARINE SODIQUE | 4500 UI/0,45ML | SOL INJ | B/2 | LEO | E | V | CS 03/05/2019 |
67 | PICOPREP | PICOSULFATE DE SODIUM, OXYDE DE MAGNESIUM LEGER,ACIDE CITRIQUE ANHYDRE | 10,0MG/3,5G/12,0G | PDRE PR SOL BUV | B/02 SACHETS | FERRING ARZNEIMITTEL GmbH | E | T | Transfert 07/05/2019 |
68 | LIBLAB | EXTRAIT DE SEC DE FEUILLES DE LIERRE | 35,7 MG | COMPRIME A SUCER | B/20 | DAR EL DAWA | C | N | 10/05/2019 |
69 | RISDONE | RISPERIDONE | 1MG/ML | SOL BUVABLE | FL/60ML | DAR EL DAWA | E | N | 10/05/2019 |
70 | RISDONE | RISPERIDONE | 1 MG/ML | SOL BUVABLE | FL/30ML | DAR EL DAWA | E | N | 10/05/2019 |
71 | SOLUVIT | MELANGE DES VITAMINES HYDROSOLUBLES | LYOPHILISAT PREP INJ | b/10/10ML | FRESENIUS KABI | C | N | 10/05/2019 | |
72 | CERTICAN | EVEROLIMUS | 0,5 MG | COMPRIME | b/60 | NOVARTIS PHARMA | V | N | 13/05/2019 |
73 | SIMULECT | BASILIXIMAB | 20 MG | PDRE P PREP INJ | B/1F + S /5ML | NOVARTIS PHARMA | V | T | CS 16/05/2019 |
74 | ASPEGIC | ACETYL SALICYLATE DE LYSINE | 500 MG | PDRE PPREP INJ | B/20 FL | SANOFI AVENTIS | E | V | CS 16/05/2019 |
75 | ASPEGIC | ACETYL SALICYLATE DE LYSINE | 500 MG | PDRE PPREP INJ | B/6 FL | SANOFI AVENTIS | E | V | CS 16/05/2019 |
76 | OXYNORM | OXYCODONE (HCL) | 10 MG | SOL INJ | B/5 AMP/1ML | NAPP PHARMACEUTICALS LIMITED | V | N | CS 16/05/2019 |
77 | OXYNORM | OXYCODONE (HCL) | 20 MG | SOL INJ | B/5 AMP/2ML | NAPP PHARMACEUTICALS LIMITED | V | N | CS 16/05/2019 |
78 | OXYCONTIN | OXYCODONE (HCL) | 80 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2019 |
79 | OXYCONTIN | OXYCODONE (HCL) | 10 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2019 |
80 | OXYCONTIN | OXYCODONE (HCL) | 15 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2019 |
81 | OXYCONTIN | OXYCODONE (HCL) | 20 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2019 |
82 | OXYCONTIN | OXYCODONE (HCL) | 30 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2019 |
83 | OXYCONTIN | OXYCODONE (HCL) | 40 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2019 |
84 | OXYCONTIN | OXYCODONE (HCL) | 60 MG | COMPRIME LP | B/20 | PURDUE PHARMA L.P | E | N | CS 16/05/2019 |
85 | BUTRANS | BUPRENORPHINE | 5µG/H | PATCHS TRANSDERMIQUE | B/4 PATCHS | NAPP PHARMACEUTICALS LIMITED | V | N | CS 16/05/2019 |
86 | BUTRANS | BUPRENORPHINE | 10µG/H | PATCHS TRANSDERMIQUE | B/4 PATCHS | NAPP PHARMACEUTICALS LIMITED | V | N | CS 16/05/2019 |
87 | BUTRANS | BUPRENORPHINE | 20µG/H | PATCHS TRANSDERMIQUE | B/4 PATCHS | NAPP PHARMACEUTICALS LIMITED | V | N | CS 16/05/2019 |
88 | GRANOCYTE | LENOGRASTIM | 34MUI/ML | POUDRE ET SOLVANT POUR SOLUTION INJECTABLE | B/05 | SANOFI | V | N | 19/06/2019 |
89 | CANCIDAS | CASPOFUNGINE | 50 MG | PDRE P PREP INJ | B/01 | MERCK SHARP &DOHME BV | E | N | 21/06/2019 |
90 | CANCIDAS | CASPOFUNGINE | 70 MG | PDRE P PREP INJ | B/01 | MERCK SHARP &DOHME BV | E | N | 21/06/2019 |
91 | VFEND | VORICONAZOLE | 200MG | PDRE PR SOL PERFUSION | B/1 | PFIZER EUROPE | E | N | TRANSFERT 27/06/2019 |
92 | XALAtAN | LATANOPROST | 50µG/ML | COLLYRE | B/3FL2,5ML | PFIZER HOLDING | E | V | CS 09/07/2019 |
93 | XALAtAN | LATANOPROST | 50µG/MG | COLLYRE | B/1/FL2,5ML | PFIZER HOLDING | E | V | CS 09/07/2019 |
94 | XALAtAN | LATANOPROST+ TIMOLOL | 50µG/5MG | COLLYRE | FL/1FL | PFIZER HOLDING | E | V | CS 09/07/2019 |
95 | XALAtAN | LATANOPROST+ TIMOLOL | 50µG/5ML | COLLYRE | B/3F | PFIZER HOLDING | E | V | CS 09/07/2019 |
Spécialités Pharmaceutiques fabriquées localement :
* Produits à évaluer pour la première fois au Comité Technique (AO)
N° | Médicament | DCI | Dosage | Forme Pharmaceutique | Présentation | Titulaire | VEIC | Type de la demande | Date BA |
1 | CYTOGEM | GEMCITABINE | 40 mg/ml (2000mg) | Solution injectable pour perfu | FL/50 ml | CYTOPHARMA | V | N | 15/07/2019 |
2 | CYTOGEM | GEMCITABINE | 40 mg/ml (200mg) | Solution injectable pour perfu | FL/5 ml | CYTOPHARMA | V | N | 15/07/2019 |
3 | GEMCITABINE NEAPOLIS | GEMCITABINE | 200 mg | Pdre p.prep.injectable | B/1 flacon | NEAPOLIS PHARMA | V | N | 16/07/2019 |
4 | GEMCITABINE NEAPOLIS | GEMCITABINE | 1 g | Pdre p.prep.injectable | B/1 flacon | NEAPOLIS PHARMA | V | N | 16/07/2019 |